Lawyers and Settlements Lawsuit News
What are you looking for?
Disability Insurance Resource Center
Home Page >> Emerging Issues >> Merck

MERCK 401 (k) RETIREMENT SAVINGS PLANS

On March 30, 2008 it was announced that Vytorin, a combination of the anti-cholesterol drugs simvastatin and Zetia, which was marketed by Merck & Co., Inc. (Merck) (NYSE: MRK), was no more effective than simvastatin alone, which is available in a substantially cheaper generic form. When the truth was revealed, Merck’s stock price fell drastically, resulting in massive losses to participants in the Merck & Co., Inc. Employee Savings & Security Plan (the Salaried Plan), the Merck & Co., Inc. Employee Stock Purchase & Savings Plan (the Hourly Plan), the Merck Puerto Rico Employee Savings & Security Plan (the Puerto Rico Plan) and the Merck-Medco Managed Care, LLC 401(k) Savings Plan (the Medco Plan) (collectively the Plans).

The investigation concerns violations of the Employee Retirement Income Security Act (ERISA) and breach of fiduciary duty claims against Defendants arising from improprieties relating to Vytorin and whether Defendants negligently failed to disclose material information about the effects of Vytorin necessary for participants to make informed decisions concerning their investments in the Merck Common Stock Fund (the Fund). A breach of ERISA-mandated fiduciary duties of loyalty and prudence to participants and beneficiaries of the Plans may have occurred if the fiduciaries failed to manage the assets of the Plans prudently and loyally by investing the in the Fund when it was no longer prudent for participants' retirement savings.

Merck employees who own Merck stock or the Fund through the Plans may be able to recover some of their losses. If you or anyone you know is a member of the Plans, please complete a Merck Complaint Form for a free evaluation.

Merck Employee Savings Plan Legal Help

If you have suffered losses to your Merck employee plan, please click the link below to send your complaint to a lawyer to evaluate your claim at no cost or obligation.


Last updated on Jul-11-08

ARTICLES AND INTERVIEWS

Merck ERISA Lawsuit Filed
Merck ERISA Lawsuit Filed Hartford, CT: A lawsuit has been filed against Merck alleging the company violated Employee Retirement Income Security Act (ERISA) laws in its managing of employee investments in Merck Plans. The lawsuit was filed June 20, 2008, in New Jersey. [ Read More ]
Merck and ERISA: Did Vytorin Constitute a Violation?
Merck and ERISA: Did Vytorin Constitute a Violation? Whitehouse Station, NJ: Merck's role in the alleged delay of the ENHANCE study that ultimately revealed the truth about Vytorin, may have served to mislead more than the drug-buying public. The two-year wait for the truth about the anti-cholesterol drug may have also served to pull the wool over the eyes of those Merck employees, and investors in various Merck employee savings plans and 401(k) plans incurring huge losses. [ Read More ]
Possible Merck ERISA Violation Regarding Vytorin
Possible Merck ERISA Violation Regarding Vytorin Whitehouse Station, NJ: When Merck dragged its feet for 21 months before releasing the ENHANCE study shaming Vytorin, the manufacturer allegedly did more than delay the bad news: it may have also delayed the returns, and derailed the retirement plans of thousands of investors unaware of a ticking time bomb. But Merck knew, and in so doing may have breached its fiduciary duty to investors under ERISA guidelines. [ Read More ]

YOUR STORIES

Publish your experience here for our readers to learn from.

Search

Search 10,000 recent
cases and settlements
 
FAQ | TOS | Privacy | Disclaimer | About Us | Contact Us | Press | Advertise | Member Login | Link to Us | Site Map

© 2001-2010 Online Legal Media. All rights reserved.